(Thanks to Israel21c) The US FDA has just approved ForeseeHome, developed by Israel’s Notal Vision, which allows patients suffering age-related macular degeneration (AMD) to monitor the progression of the condition in their own homes. It is vital to identify immediately when “dry” AMD changes to “wet” AMD at which point they can be treated.
http://israel21c.org/health/first-fda-cleared-home-monitor-for-macular-degeneration/